Chiodi V - Search Results

1

Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A_2A Receptor-Mediated Effects in the Central Nervous System.

Domenici MR, Mallozzi C, Pepponi R, Casella I, Chiodi V, Ferrante A, Popoli P. Domenici MR, et al. Among authors: chiodi v. Front Pharmacol. 2021 Apr 19;12:647742. doi: 10.3389/fphar.2021.647742. eCollection 2021. Front Pharmacol. 2021. PMID: 33953681 Free PMC article.

2

Maternal exposure to low levels of corticosterone during lactation protects the adult offspring against ischemic brain damage.

Casolini P, Domenici MR, Cinque C, Alemà GS, Chiodi V, Galluzzo M, Musumeci M, Mairesse J, Zuena AR, Matteucci P, Marano G, Maccari S, Nicoletti F, Catalani A. Casolini P, et al. Among authors: chiodi v. J Neurosci. 2007 Jun 27;27(26):7041-6. doi: 10.1523/JNEUROSCI.1074-07.2007. J Neurosci. 2007. PMID: 17596453 Free PMC article.

3

Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.

Tebano MT, Martire A, Chiodi V, Pepponi R, Ferrante A, Domenici MR, Frank C, Chen JF, Ledent C, Popoli P. Tebano MT, et al. Among authors: chiodi v. J Neurochem. 2009 Sep;110(6):1921-30. doi: 10.1111/j.1471-4159.2009.06282.x. Epub 2009 Jul 17. J Neurochem. 2009. PMID: 19627447 Free article.

4

Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.

Ferrante A, Martire A, Armida M, Chiodi V, Pézzola A, Potenza RL, Domenici MR, Popoli P. Ferrante A, et al. Among authors: chiodi v. Brain Res. 2010 Apr 6;1323:184-91. doi: 10.1016/j.brainres.2010.01.080. Epub 2010 Feb 4. Brain Res. 2010. PMID: 20138162

5

Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease.

Tebano MT, Martire A, Chiodi V, Ferrante A, Popoli P. Tebano MT, et al. Among authors: chiodi v. ScientificWorldJournal. 2010 Sep 1;10:1768-82. doi: 10.1100/tsw.2010.164. ScientificWorldJournal. 2010. PMID: 20842321 Free PMC article. Review.

6

Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.

Martire A, Tebano MT, Chiodi V, Ferreira SG, Cunha RA, Köfalvi A, Popoli P. Martire A, et al. Among authors: chiodi v. J Neurochem. 2011 Jan;116(2):273-80. doi: 10.1111/j.1471-4159.2010.07101.x. Epub 2010 Dec 2. J Neurochem. 2011. PMID: 21062287 Free article.

7

Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.

Chiodi V, Uchigashima M, Beggiato S, Ferrante A, Armida M, Martire A, Potenza RL, Ferraro L, Tanganelli S, Watanabe M, Domenici MR, Popoli P. Chiodi V, et al. Neurobiol Dis. 2012 Mar;45(3):983-91. doi: 10.1016/j.nbd.2011.12.017. Epub 2011 Dec 23. Neurobiol Dis. 2012. PMID: 22207189

8

BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved.

Martire A, Pepponi R, Domenici MR, Ferrante A, Chiodi V, Popoli P. Martire A, et al. Among authors: chiodi v. J Neurochem. 2013 Apr;125(2):225-35. doi: 10.1111/jnc.12177. Epub 2013 Feb 27. J Neurochem. 2013. PMID: 23363456 Free article.

9

Cocaine-induced changes of synaptic transmission in the striatum are modulated by adenosine A2A receptors and involve the tyrosine phosphatase STEP.

Chiodi V, Mallozzi C, Ferrante A, Chen JF, Lombroso PJ, Di Stasi AM, Popoli P, Domenici MR. Chiodi V, et al. Neuropsychopharmacology. 2014 Feb;39(3):569-78. doi: 10.1038/npp.2013.229. Epub 2013 Aug 30. Neuropsychopharmacology. 2014. PMID: 23989619 Free PMC article.

10

Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.

De Filippis B, Valenti D, Chiodi V, Ferrante A, de Bari L, Fiorentini C, Domenici MR, Ricceri L, Vacca RA, Fabbri A, Laviola G. De Filippis B, et al. Among authors: chiodi v. Eur Neuropsychopharmacol. 2015 Jun;25(6):889-901. doi: 10.1016/j.euroneuro.2015.03.012. Epub 2015 Mar 30. Eur Neuropsychopharmacol. 2015. PMID: 25890884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page